Recombinant Zoster Vaccine Is Safe and Effective After Allogeneic Hematopoietic Cell Transplantation
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Blood Advances
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Safety and Reactogenicity of the Recombinant Zoster Vaccine After Allogeneic Hematopoietic Cell Transplantation
Blood Adv 2021 Mar 23;5(6)1585-1593, E Baumrin, NE Izaguirre, B Bausk, MM Feeley, CP Bay, Q Yang, VT Ho, LR Baden, NC IssaFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.